Insider Transactions in Q3 2024 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
7,492
-0.3%
|
$0
$0.86 P/Share
|
|
Aug 25
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,508
-0.18%
|
$0
$0.86 P/Share
|
|
Aug 25
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-0.17%
|
$0
$0.86 P/Share
|
|
Aug 25
2024
|
Amy Pooler VP, HEAD OF RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
493
-0.25%
|
$0
$0.86 P/Share
|
|
Aug 25
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-0.16%
|
$0
$0.86 P/Share
|
|
Aug 24
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
5,261
-0.21%
|
$0
$0.86 P/Share
|
|
Aug 24
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-0.21%
|
$0
$0.86 P/Share
|
|
Aug 24
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-0.22%
|
$0
$0.86 P/Share
|
|
Aug 24
2024
|
Amy Pooler VP, HEAD OF RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-0.36%
|
$0
$0.86 P/Share
|
|
Aug 24
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-0.17%
|
$0
$0.86 P/Share
|
|
Aug 13
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-0.11%
|
$0
$0.98 P/Share
|